References
- Gajecka M, Mackay KL, Shaffer LG. Monosomy 1p36 deletion syndrome. Am J Med Genet C Semin Med Genet 2007;145C:346-56. https://doi.org/10.1002/ajmg.c.30154
- Heilstedt HA, Ballif BC, Howard LA, Kashork CD, Shaffer LG. Population data suggest that deletions of 1p36 are a relatively common chromosome abnormality. Clin Genet 2003;64:310-6. https://doi.org/10.1034/j.1399-0004.2003.00126.x
- Shaffer LG, Lupski JR. Molecular mechanisms for constitutional chromosomal rearrangements in humans. Annu Rev Genet 2000;34:297-329. https://doi.org/10.1146/annurev.genet.34.1.297
- Shapira SK, McCaskill C, Northrup H, Spikes AS, Elder FF, Sutton VR, et al. Chromosome 1p36 deletions: the clinical phenotype and molecular characterization of a common newly delineated syndrome. Am J Hum Genet 1997;61:642-50. https://doi.org/10.1086/515520
- Giraudeau F, Taine L, Biancalana V, Delobel B, Journel H, Missirian C, et al. Use of a set of highly polymorphic minisatellite probes for the identification of cryptic 1p36.3 deletions in a large collection of patients with idiopathic mental retardation. J Med Genet 2001;38:121-5. https://doi.org/10.1136/jmg.38.2.121
- Riegel M, Castellan C, Balmer D, Brecevic L, Schinzel A. Terminal deletion, del(1)(p36.3), detected through screening for terminal deletions in patients with unclassified malformation syndromes. Am J Med Genet 1999;82:249-53. https://doi.org/10.1002/(SICI)1096-8628(19990129)82:3<249::AID-AJMG10>3.0.CO;2-8
- Rosenfeld JA, Crolla JA, Tomkins S, Bader P, Morrow B, Gorski J, et al. Refinement of causative genes in monosomy 1p36 through clinical and molecular cytogenetic characterization of small interstitial deletions. Am J Med Genet A 2010;152A:1951-9. https://doi.org/10.1002/ajmg.a.33516
- Heilstedt HA, Ballif BC, Howard LA, Lewis RA, Stal S, Kashork CD, et al. Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterization of the syndrome. Am J Hum Genet 2003;72:1200-12. https://doi.org/10.1086/375179
- Heilstedt HA, Burgess DL, Anderson AE, Chedrawi A, Tharp B, Lee O, et al. Loss of the potassium channel beta-subunit gene, KCNAB2, is associated with epilepsy in patients with 1p36 deletion syndrome. Epilepsia 2001;42:1103-11.
- Kurosawa K, Kawame H, Okamoto N, Ochiai Y, Akatsuka A, Kobayashi M, et al. Epilepsy and neurological findings in 11 individuals with 1p36 deletion syndrome. Brain Dev 2005;27:378-82. https://doi.org/10.1016/j.braindev.2005.02.004
- Bahi-Buisson N, Guttierrez-Delicado E, Soufflet C, Rio M, Daire VC, Lacombe D, et al. Spectrum of epilepsy in terminal 1p36 deletion syndrome. Epilepsia 2008;49:509-15. https://doi.org/10.1111/j.1528-1167.2007.01424.x
- Wang XB, Funada M, Imai Y, Revay RS, Ujike H, Vandenbergh DJ, et al. rGbeta1: a psychostimulant-regulated gene essential for establishing cocaine sensitization. J Neurosci 1997;17:5993-6000. https://doi.org/10.1523/JNEUROSCI.17-15-05993.1997
- Windpassinger C, Kroisel PM, Wagner K, Petek E. The human gamma-aminobutyric acid A receptor delta (GABRD) gene: molecular characterisation and tissue-specific expression. Gene 2002;292:25-31. https://doi.org/10.1016/S0378-1119(02)00649-2
- Atanasoski S, Notterpek L, Lee HY, Castagner F, Young P, Ehrengruber MU, et al. The protooncogene Ski controls Schwann cell proliferation and myelination. Neuron 2004;43:499-511. https://doi.org/10.1016/j.neuron.2004.08.001
- Edwards TJ, Sherr EH, Barkovich AJ, Richards LJ. Clinical, genetic and imaging findings identify new causes for corpus callosum development syndromes. Brain 2014;137(Pt 6):1579-613. https://doi.org/10.1093/brain/awt358